Drug sensitivity profiling of 3D tumor tissue UGent BiblioUGent Biblio
biblio.ugent.be
von H Peterziel · · Zitiert von: 13 — Jones, Jani Saarela, Vilja Pietiäinen, Natalie Jäger, Matthias Schlesner, Annette Kopp-Schneider, Sina Oppermann, Till Milde, Olaf Witt, and Ina ... von H Peterziel · · Zitiert von: 13 — Jones, Jani Saarela, Vilja Pietiäinen, Natalie Jäger, Matthias Schlesner, Annette Kopp-Schneider, Sina Oppermann, Till Milde, Olaf Witt, and Ina ...
Molecular Mechanisms Underlying OxytosisWiley Online Library
onlinelibrary.wiley.com
von AM Dolga · · Zitiert von: 7 — Sina Oppermann,. Sina Oppermann. German Cancer Research Center (DKFZ) and National Center of Tumordiseases (NCT), Heidelberg, Germany. Search ... von AM Dolga · · Zitiert von: 7 — Sina Oppermann,. Sina Oppermann. German Cancer Research Center (DKFZ) and National Center of Tumordiseases (NCT), Heidelberg, Germany. Search ...
High-content screening identifies kinase ASH Publicationsashpublications.org
ashpublications.org
von S Oppermann · · Zitiert von: 116 — Sina Oppermann,. Sina Oppermann. 1Biology Platform, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada;. Search for ...
N‐Acyl Derivatives of 4‐Phenoxyaniline as Neuroprotective ...Chemistry Europe
chemistry-europe.onlinelibrary.wiley.com
von MT Barho · · Zitiert von: 17 — These authors contributed equally to this work. Search for more papers by this author · Sina Oppermann,. Sina Oppermann. Department of ...
Leveraging the BCL-2 Interactome to Kill Cancer Cells ...aacrjournals.org
aacrjournals.org
von H Brahmbhatt · · Zitiert von: 38 — Sina Oppermann;. Sina Oppermann. 2Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. Search for other works by this author on ... von H Brahmbhatt · · Zitiert von: 38 — Sina Oppermann;. Sina Oppermann. 2Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. Search for other works by this author on ...
and combination therapy dose response profiling data ...ScienceDirect.com
www.sciencedirect.com
von D ElHarouni · · Zitiert von: 13 — , Olaf Witt b e h , Matthias Schlesner a i 1 , Sina Oppermann b e 1. Show more. Add to Mendeley. Share. Cite. https://doi.org j.phrs von D ElHarouni · · Zitiert von: 13 — , Olaf Witt b e h , Matthias Schlesner a i 1 , Sina Oppermann b e 1. Show more. Add to Mendeley. Share. Cite. https://doi.org j.phrs
Drug sensitivity profiling of 3D tumor tissue cultures OPUS 4Universität Augsburg
opus.bibliothek.uni-augsburg.de
von H Peterziel · · Zitiert von: 9 — ... Sina Oppermann, Till Milde, Olaf Witt, Ina Oehme. URN: urn:nbn:de:bvb:384-opus Frontdoor URL, https://opus.bibliothek.uni-augsburg.de ...
Combination drug screen identifies synergistic ...Springer
link.springer.com
von S Zeuner · · Zitiert von: 1 — Simon Zeuner, Johanna Vollmer, Romain Sigaud, Sina Oppermann, Heike Peterziel, Ina Oehme, Olaf Witt, Till Milde & Jonas Ecker. National ... von S Zeuner · · Zitiert von: 1 — Simon Zeuner, Johanna Vollmer, Romain Sigaud, Sina Oppermann, Heike Peterziel, Ina Oehme, Olaf Witt, Till Milde & Jonas Ecker. National ...
Drug sensitivity profiling of 3D tumor tissue cultures in the ...Nature
www.nature.com
von H Peterziel · · Zitiert von: 9 — van Tilburg, David T. W. Jones, Natalie Jäger, Sina Oppermann, Till Milde, Olaf Witt & Ina Oehme. Clinical Cooperation Unit Pediatric ...
Alle Infos zum Namen "Sina Oppermann"
BID links ferroptosis to mitochondrial cell death pathwaysRijksuniversiteit Groningen
research.rug.nl
von S Neitemeier · · Zitiert von: 278 — ... Sina Oppermann, Carsten Culmsee. Molecular Pharmacology · Groningen Research Institute for Asthma and COPD (GRIAC). Research output ... von S Neitemeier · · Zitiert von: 278 — ... Sina Oppermann, Carsten Culmsee. Molecular Pharmacology · Groningen Research Institute for Asthma and COPD (GRIAC). Research output ...
Combination drug screen identifies synergistic ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von S Zeuner · · Zitiert von: 1 — ... Romain Sigaud , Sina Oppermann , Heike Peterziel , Dina ElHarouni , Ina Oehme , Olaf Witt , Till Milde von S Zeuner · · Zitiert von: 1 — ... Romain Sigaud , Sina Oppermann , Heike Peterziel , Dina ElHarouni , Ina Oehme , Olaf Witt , Till Milde
Drug-perturbation-based stratification of blood cancer.Europe PMC
europepmc.org
von S Dietrich · · Zitiert von: 150 — ... Sina Oppermann. Molecular Therapy in Hematology and Oncology, and Department ... Sina Oppermann,3 Marina Lukas,3 Vladislav Kim,1 Martin Sill,8 Axel Benner,8 ...
High-content screening identifies kinase inhibitors that ...Elsevier
ohiostate.elsevierpure.com
von S Oppermann · · Zitiert von: 116 — Sina Oppermann, Jarkko Ylanko, Yonghong Shi, Santosh Hariharan, Christopher C. Oakes, Patrick M. Brauer, Juan C. Zúñiga-Pflücker, Brian Leber, David E ... von S Oppermann · · Zitiert von: 116 — Sina Oppermann, Jarkko Ylanko, Yonghong Shi, Santosh Hariharan, Christopher C. Oakes, Patrick M. Brauer, Juan C. Zúñiga-Pflücker, Brian Leber, David E ...
Janus and PI3-kinases mediate glucocorticoid resistance ...Oncotarget
www.oncotarget.com
von S Oppermann · · Zitiert von: 17 — https://doi.org oncotarget Sina Oppermann, Avery J. Lam, Stephanie Tung, Yonghong Shi, Lindsay McCaw, Guizhei Wang, ...
Novel N-phenyl-substituted thiazolidinediones protect ...Europe PMC
europepmc.org
von S Oppermann · · Zitiert von: 23 — Sina Oppermann · Florian C Schrader · Katharina Elsässer · Amalia Dolga · Anna Lena Kraus · Nunzianna Doti · Christof Wegscheid-Gerlach · Martin Schlitzer.
Patient-by-Patient Deep Transfer Learning for Drug- ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von Y Berker · · Zitiert von: 6 — ... Sina Oppermann. PMID: ; DOI: TMI Abstract. Image-based phenotypic drug profiling is receiving increasing attention in drug ... von Y Berker · · Zitiert von: 6 — ... Sina Oppermann. PMID: ; DOI: TMI Abstract. Image-based phenotypic drug profiling is receiving increasing attention in drug ...
Drug sensitivity profiling of 3D tumor tissue cultures in the ...Helsinki.fi
researchportal.helsinki.fi
von H Peterziel · · Zitiert von: 1 — ... Vilja Pietiäinen, Natalie Jaeger, Matthias Schlesner, Annette Kopp-Schneider, Sina Oppermann, Till Milde, Olaf Witt, Ina Oehme.
Drug sensitivity profiling of 3D tumor tissue cultures in the ...Tampere University Research Portal
researchportal.tuni.fi
von H Peterziel · · Zitiert von: 1 — ... Jani Saarela, Vilja Pietiäinen, Natalie Jäger, Matthias Schlesner, Annette Kopp-Schneider, Sina Oppermann, Till Milde, Olaf Witt, Ina Oehme Show 26 more
Drug-perturbation-based stratification of blood cancerJournal of Clinical Investigation
www.jci.org
von S Dietrich · · Zitiert von: 135 — Oakes,6,7 Shihui Wang,3Sina Oppermann,3 Marina Lukas,3 Vladislav Kim,1 Martin Sill,8 Axel Benner,8 Anna Jauch,9 Lesley Ann Sutton,10 Emma Young ...
Interaction between BID and VDAC1 is required for ...bioRxiv
www.biorxiv.org
von S Oppermann · · Zitiert von: 1 — Interaction between BID and VDAC1 is required for mitochondrial demise and cell death in neurons. View ORCID ProfileSina Oppermann, Barbara ...
High-content screening identifies kinase inhibitors that ...Europe PMC
europepmc.org
von S Oppermann · · Zitiert von: 106 — High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells. Sina Oppermann,1 Jarkko Ylanko,1 Yonghong Shi,1 ...
and tBid-Induced ToxicityASPET Journals
jpet.aspetjournals.org
von S Oppermann · · Zitiert von: 21 — Sina Oppermann, Florian C. Schrader, Katharina Elsässer, Amalia M. Dolga,. Anna Lena Kraus, Nunzianna Doti, Christof Wegscheid-Gerlach, Martin Schlitzer,. › content › jpet › 273.full.pdf
sortiert nach Relevanz / Datum